After 14 years of exceptional leadership, Professor Ian Sanne, director of CHRU is stepping down as ACTG vice president over the coming year. Farewell also to Dr Judy Currier, ACTG chair, whose contributions have left a lasting impact. CHRU developed a farewell video for Dr Currier starring the CHRU choir. Enjoy! The ACTG continues its work as the world’s largest and longest-running clinical trials network focussed on infectious diseases to improve the lives of those it serves. https://lnkd.in/dZqm-kHy
Clinical HIV Research Unit
Research
Johannesburg, Gauteng 479 followers
Global African infectious disease clinical trial research unit
About us
Established in 1997, the Clinical HIV Research Unit (CHRU) conducts clinical trials for the improved standard of care for the treatment of HIV, TB, HIV-associated diseases as well as Covid-19. CHRU clinical research sites are operational in Johannesburg, Durban and Gqeberha, South Africa. CHRU is committed to excellent, quality clinical research and is proud to have contributed to the breakthrough science which has improved the standard of treatment of infectious diseases within public healthcare. If you would like more information about participating in an ethical clinical trial, please be in touch. www.chru.co.za
- Website
-
http://www.chru.co.za
External link for Clinical HIV Research Unit
- Industry
- Research
- Company size
- 51-200 employees
- Headquarters
- Johannesburg, Gauteng
- Type
- Nonprofit
- Founded
- 2001
Locations
-
Primary
Helen Joseph Hospital 1 Perth Road Westdene
Johannesburg, Gauteng 2092, ZA
Employees at Clinical HIV Research Unit
Updates
-
The Clinical HIV Research Unit (CHRU) proudly celebrates Ina de Jongh’s 25 years of outstanding service! Ina, head of CHRU operations, has been with us since the start, and her commitment is a true inspiration. We are grateful for her invaluable contribution over the years. What a remarkable milestone! Thank you, Ina. #CHRU #WitsHealthConsortium #25Years
-
We are proud to share that the Clinical HIV Research Unit’s work at the 2024 Union World Conference on Lung Health in Bali was met with great enthusiasm! Trials like NC009 and Paradigm are being recognised globally. Special thanks to Dr @Takondwa Kachoka from Isango Lethemba in Gqeberha or contributing to this potentially ground-breaking research. We also thank @Dr Pauline Howell for her outstanding contribution at the 2024 Prism TB Conference. Her efforts in engaging and strengthening stakeholder relationships are crucial for our mission at CHRU. We are committed to the fight against TB! #CHRU #ClinicalTrials
-
CHRU hosted a candlelight prayer service to observe World AIDS Day this month and to challenge HIV/Aids stigma. CHRU expresses heartfelt thanks to all the community organisations that participated. Your presence and shared commitment to the fight against HIV/Aids made this event truly meaningful. Together, we continue to strengthen our community and raise awareness. #WorldAIDSDay #HIVAwareness
-
Join CHRU at Diepsloot Ext 13 Sport ground tomorrow from 9am - 2pm. CHRU is working in partnership with the Gender-based Violence Forum. We unite to end violence against women and girls. #StopGenderBasedViolence Let's create a better Diepsloot for all.
-
CHRU Sizwe received the latest International Maternal Pediatric Adolescent AIDS Clinical Trials Network (IMPAACT) Award achieving 𝙩𝙤𝙥 𝙚𝙣𝙧𝙤𝙡𝙡𝙞𝙣𝙜 𝙨𝙞𝙩𝙚 f𝙤𝙧 𝙏𝘽 𝙨𝙩𝙪𝙙𝙞𝙚𝙨 𝙞𝙣 𝙩𝙝𝙚 𝙡𝒂𝙨𝙩 𝙮𝙚𝒂𝙧! Congratulations CHRU Sizwe! Your efforts are making a difference! IMPAACT Network conducts high-quality clinical trials that advance the prevention and treatment of HIV and its complications for infants, children, adolescents, and pregnant/postpartum women globally. Photographed are Dr Pauline Howell, deputy director at the Clinical HIV Research Unit and Linah Baloyi, senior study co-ordinator for CHRU Sizwe receiving the IMPAACT Award
-
VOA News interviewed Dr Francesca Conradie, Dr Pauline Howell of the Clinical HIV Research Unit (CHRU) and USAID Southern Africa about the groundbreaking results of the BEAT Tuberculosis study that have transformed TB treatment options worldwide for all, including children and pregnant women. The BEAT Tuberculosis study marks a significant breakthrough in the fight against drug-resistant TB. Watch this piece on Voice of America: https://lnkd.in/d8anTBTK Together, we can #BeatTB!
-
Cabinet has congratulated CHRU and all the South African researchers involved in the groundbreaking BEAT Tuberculosis study. Now pregnant women and children can access this improved treatment too! "𝑪𝒂𝒃𝒊𝒏𝒆𝒕 𝒆𝒙𝒕𝒆𝒏𝒅𝒆𝒅 𝒊𝒕𝒔 𝒄𝒐𝒏𝒈𝒓𝒂𝒕𝒖𝒍𝒂𝒕𝒊𝒐𝒏𝒔 𝒂𝒏𝒅 𝒘𝒆𝒍𝒍 𝒘𝒊𝒔𝒉𝒆𝒔 𝒕𝒐 𝑺𝒐𝒖𝒕𝒉 𝑨𝒇𝒓𝒊𝒄𝒂𝒏 𝒓𝒆𝒔𝒆𝒂𝒓𝒄𝒉𝒆𝒓𝒔 𝒊𝒏𝒗𝒐𝒍𝒗𝒆𝒅 𝒊𝒏 𝒕𝒉𝒆 𝒈𝒓𝒐𝒖𝒏𝒅𝒃𝒓𝒆𝒂𝒌𝒊𝒏𝒈 𝒔𝒕𝒖𝒅𝒚, 𝑩𝑬𝑨𝑻 𝑻𝒖𝒃𝒆𝒓𝒄𝒖𝒍𝒐𝒔𝒊𝒔, 𝒘𝒉𝒊𝒄𝒉 𝒉𝒂𝒔 𝒃𝒆𝒄𝒐𝒎𝒆 𝒕𝒉𝒆 𝒘𝒐𝒓𝒍𝒅’𝒔 𝒇𝒊𝒓𝒔𝒕 𝒑𝒓𝒐𝒈𝒓𝒂𝒎𝒎𝒆 𝒊𝒏 𝒕𝒉𝒆 𝒃𝒂𝒕𝒕𝒍𝒆 𝒂𝒈𝒂𝒊𝒏𝒔𝒕 𝒅𝒓𝒖𝒈-𝒓𝒆𝒔𝒊𝒔𝒕𝒂𝒏𝒕 𝒕𝒖𝒃𝒆𝒓𝒄𝒖𝒍𝒐𝒔𝒊𝒔 𝒇𝒐𝒓 𝒂𝒍𝒍 𝒑𝒐𝒑𝒖𝒍𝒂𝒕𝒊𝒐𝒏 𝒈𝒓𝒐𝒖𝒑𝒔, 𝒊𝒏𝒇𝒍𝒖𝒆𝒏𝒄𝒊𝒏𝒈 𝒕𝒉𝒆 𝒊𝒏𝒕𝒆𝒓𝒏𝒂𝒕𝒊𝒐𝒏𝒂𝒍 𝑻𝑩 𝒕𝒓𝒆𝒂𝒕𝒎𝒆𝒏𝒕 𝒑𝒐𝒍𝒊𝒄𝒚 𝒐𝒇 𝒕𝒉𝒆 𝑾𝒐𝒓𝒍𝒅 𝑯𝒆𝒂𝒍𝒕𝒉 𝑶𝒓𝒈𝒂𝒏𝒊𝒔𝒂𝒕𝒊𝒐𝒏." Well done to all our stakeholders, the USAID - US Agency for International Development (USAID), National Department of Health (South Africa), Wits - University of the Witwatersrand and the Eastern Cape Department of Health and KwaZulu-Natal Department of Health for their dedicated efforts in the success of this study. Together we can #BeatTB!